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A Critical Role for Complement
in Maintenance of Self-Tolerance
Molina et al., 1996) have an impaired humoral response
to thymus-dependent antigens characterized by re-
duced number and size of germinal centers (GC). CD21
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Lisa Chu,* Elisabeth M. Alicot,*
Christopher C. Goodnow,² and Michael C. Carroll*³ (molecular weight 150 kDa) and CD35 (molecular weight
*The Center for Blood Research 190 kDa) are coexpressed on B cells and follicular den-
Department of Pathology dritic cells (FDC); they are both encoded at the Cr2 locus,
Harvard Medical School as CD21 is derived from CD35 by alternative splicing.
Boston, Massachusetts 02115 Expression of CD21/CD35 is essential in at least two
²Medical Genome Centre stages of B cell response to antigen: (1) retention within
John Curtin School of Medical Research the lymphoid follicles and (2) GC survival (Fischer et al.,
Canberra 2601 1998a). Survival of GC B cells is mediated by contact
Australia between C3d antigen±decorated FDC and the B cell
coreceptor, a membrane complex of CD21/CD19/CD81
(Fischer et al., 1998a; Qin et al., 1998).
Summary To determine if complement is also involved in nega-
tive selection of self-reactive B cells, two approaches
The role of complement in the maintenance of self- were taken. In the first, Cr2null and Cr21 mice were bred
tolerance has been examined in two models: an immu- with transgenic mice expressing transgenes encoding
noglobulin transgenic model of peripheral tolerance either soluble hen egg lysozyme (sHEL; ML5) or high-
and a lupus-like murine model of CD95 (Fas) defi- affinity HEL-specific immunoglobulin (Ig; strain MD4)
ciency. We find that self-reactive B lymphocytes defi- (Goodnow et al., 1995). Breeding of the Cr2null or Cr21
cient in complement receptors CD21/CD35 or trans- Ig with sHEL mice provided a model to study the role
ferred into mice deficient in the complement protein of CD21/CD35 in B cell negative selection induced by a
C4 are not anergized by soluble self-antigen. In the defined self-antigen, i.e., sHEL. In the double-transgenic
second model, deficiency in CD21/CD35 or C4 com- mice, HEL-binding B cells are anergized upon contact
bined with CD95 deficiency results in high titers of with sHEL self-antigen within the bone marrow but es-
anti-nuclear antibodies leading to severe lupus-like cape to the periphery where they have a dramatically
disease. These findings suggest a novel role for the reduced half life (Fulcher and Basten, 1994) and are
complement system in B cell tolerance and provide possibly eliminated by a Fas-dependent mechanism
insight into the genetic association of complement
(Rathmell et al., 1995). In the periphery, anergic HEL-
deficiency with susceptibility to systemic lupus erythe-
binding B lymphocytes exhibit a dramatic reduction in
matosus.
surface IgM expression (mIgM); ex vivo, they fail to re-
spond to cross-linking of mIgM, even in the presenceIntroduction
of T cell help (Cooke et al., 1994). By contrast, we find
that Cr2null HEL-binding B lymphocytes accumulate inSystemic lupus erythematosus (SLE) is a common auto-
the spleen and lymph nodes of sHEL transgenic miceimmune disorder with a prevalence as high as 1 in 2500
at normal frequencies, have an increased life span com-individuals and a male to female ratio of 1 to 9 (Michet
pared to Cr21 B cells, and respond to HEL self-antigenet al., 1985; Cotran et al., 1994). It is characterized by
ex vivo by changes in intracellular calcium ion (Ca21i)dysregulation of self-reactive B lymphocytes resulting
and expression of the activation marker CD86 (B7±2).in anti-nuclear and -dsDNA antibodies. Although unex-
Importantly, the complement component C4 is criticalplained, a major risk factor is deficiency in serum com-
for the maintenance of self-tolerance, as Ig transgenicplement proteins C1, C2, or C4, as affected individuals
B cells are not anergized in the presence of sHEL in(male and female equally) almost always develop SLE
C4null mice. In the second model, mice deficient in CD21/(Agnello, 1978; Walport and Morgan, 1991). Interest-
CD35, C4, or C3 were bred with CD95 (Fas) deficientingly, deficiency in C3 is not a major risk factor. Recent
mice (C57BL/6.lpr/lpr), which have a mild form of lupus-results from biochemical studies (Fearon and Carter,
like disease (Theofilopoulos and Dixon, 1985). Mice1995) and knockout mice (Carroll, 1998a) provide new
insight into an essential role for the complement system bearing the combined deficiency of Cr2null or C4null and
in the activation and formation of memory B lympho- lpr/lpr developed a dramatic increase in anti-nuclear
cytes to thymus-dependent antigens (Pepys, 1972; and -dsDNA antibodies, lymphadenopathy, and glomer-
Klaus et al., 1980). For example, mice deficient in either ulonephritis. By contrast, C3null lpr/lpr mice did not de-
C3 (C3null) or C4 (C4null) (Fischer et al., 1996) (C4 is required velop increased autoantibodies and disease was only
in C3 activation) or complement receptors CD21 and modestly increased compared to complement-suffi-
CD35 (Cr2null) (Ahearn et al., 1996; Croix et al., 1996; cient (C1) lpr/lpr controls. These results support the
hypothesis that complement is important in negative
selection of self-reactive B cells and provide an explana-³ To whom correspondence should be addressed (e-mail: mcarroll@
tion for the paradox in which complement deficiency isrics.bwh.harvard.edu).
§ These authors contributed equally to this work. associated with autoimmunity.
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Figure 1. Surface IgMa Expression on Immature Bone Mature B Lymphocytes Is Not Reduced in Cr2null Mice in the Presence of sHEL
(A and B) Representative histograms of relative IgMa fluorescence of HEL-binding B cells of single- and double-transgenic Cr21 and Cr2null
mice.
(C) Scatter plot summarizing results from at least three separate experiments. Results reveal that Cr2null HEL-binding B cells do not downregulate
surface IgM in the presence of HEL self-antigen. Horizontal bars represent mean values.
Results single- and double-transgenic mice confirmed that a
higher frequency of Cr2null than Cr21 HEL-binding B cells
were accumulating within the splenic follicles of double-Cr2null HEL-Binding B Lymphocytes Mature
and Accumulate Normally in the Presence transgenic mice (data not shown). These results suggest
that in the absence of CD21/CD35 expression, self-reac-of sHEL Self-Antigen
Encounter of immature (IgM1, IgD2, CD232) HEL-bind- tive B cells are not anergized, but they continue to ma-
ture and accumulate within the peripheral compartment.ing B cells with sHEL in the bone marrow results in
downregulation of membrane IgM (mIgM) (Figures 1A± This apparent break in tolerance is not due to an inherent
difference in the level of self-antigen or antibody in the1C). By contrast, relative mIgM expression actually in-
creases on Cr2null self-reactive B cells in the presence deficient mice, because sHEL and HEL-specific anti-
body in serum of Cr2null single-transgenic mice was com-of self-antigen (225 6 14 versus 380 6 48 relative units
of intensity, p , 0.013, respectively) (Figures 1A±1C). parable to that of Cr21 controls (data not shown).
sHEL self-antigen has a more striking effect on theThree-color flow cytometry analysis confirmed that these
were mIgD-negative immature B cells (data not shown). accumulation of anergic B cells in the peripheral lymph
nodes (LN), as the frequency of HEL-binding B cells wasThese results demonstrate that CD21/CD35 is involved
in negative selection of B cells and suggest that comple- 3-fold less in double- than single-transgenic mice (Table
1). When all HEL-binding LN cells were analyzed forment is enhancing either B cell signaling or localization
of HEL self-antigen to the bone marrow (BM). expression of CD23, a marker for mature B cells, an
even greater difference was found (Table 1). A modestExamination of splenocytes harvested from Cr21 sin-
gle- and double-transgenic mice by three-color flow cy- decrease in the frequency of CD231 Cr2null HEL-binding
B cells was also observed in double-transgenic mice,tometry revealed a similar frequency of IgMa1B2201 B
cells that bound HEL, approximately 81%±83% (Table but it was less than 2-fold (Table 1). Thus, a significantly
higher number of mature CD231 Cr2null than of Cr21 Ig1). Interestingly, there was an approximate 2-fold differ-
ence in the number of Cr2null versus Cr21 HEL-binding transgenic B cells accumulates within the LNs (2.0 6
1.2 3 105 versus 0.5 6 0.3 3 105, p , 0.0007). To examineB cells in double-transgenic mice (52 6 13.9 3 106 versus
25 6 9.1 3 106, p , 0.00001 [Table 1]) despite a similar turnover of the HEL-binding B cells in the absence or
presence of HEL self-antigen, single- and double-decrease in the level of expression of mIgM (data not
shown). One possible explanation for the frequency in- transgenic mice were injected with BrdU each day for
seven days; LN cells were harvested and analyzed bycrease is that the Cr2null Ig transgenic B cells are posi-
tively selected by sHEL self-antigen. Consistent with three-color flow cytometry. In this assay, nondividing
cells fail to incorporate BrdU and can be distinguishedthis interpretation is the finding of a modest increase
in frequency of Cr2null HEL-binding B cells in double- from newly formed cells, which are BrdU positive. The
frequency of BrdU-negative, Cr21 HEL-binding B2201compared to single-transgenic animals both in the bone
marrow and spleen (Table 1). Histological analyses of cells in the lymph nodes of double-transgenic mice was
reduced about one-third, i.e., 76% 6 3.3% to 55% 6cryosections of spleens harvested from Cr21 and Cr2null
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12.5%, in the presence of sHEL self-antigen (Figures
2A and 2C). Thus, approximately half of the Cr21 HEL-
binding B cells were replaced within the LN during the
7 day labeling period. This finding is consistent with that
of Fulcher and Basten, who found 50% renewal rate of
about 1 week for mature HEL-binding anergic B cells
(Fulcher and Basten, 1994). Similarly, the total number
of BrdU-negative, Cr21 HEL-binding B2201 cells within
the LNs was reduced approximately 3-fold (7.5 6 1.62 3
105 versus 1.8 6 0.64 3 105, p , 0.0001) in the presence
of sHEL antigen (Figure 2E). By contrast, very little differ-
ence was observed in the renewal of Cr2null HEL-binding
B2201 cells in the absence or presence of HEL self-
antigen, i.e., 75% 6 4.7% BrdU negative versus 74% 6
4.8% BrdU negative, respectively (Figures 2B and 2D).
Similarly, the total number of BrdU-negative Cr2null HEL-
binding B2201 cells did not change significantly in the
presence of HEL self-antigen (Figure 2E). Thus, the pres-
ence of HEL self-antigen did not appear to alter signifi-
cantly the turnover or total number of CD21/CD35-defi-
cient Ig transgenic B cells within the LNs. The longer
life span of the Cr2null HEL-binding B cells would explain
their increased accumulation relative to the anergic Cr21
B cells.
Cr2null HEL-Binding B Lymphocytes Respond
to Antigen Ex Vivo
In the double-transgenic model, anergic B cells are char-
acterized by their failure to respond to cross-linking of
mIgM in vitro as determined by change in intracellular
Ca21i and expression of the activation marker CD86
(B7±2) (Cooke et al., 1994). To test if the Cr2null HEL-bind-
ing B cells were anergized by sHEL self-antigen, Cr21
and Cr2null HEL-binding B cells were harvested from the
spleens of single- and double-transgenic mice and char-
acterized in vitro for their response to HEL. Splenocytes
were cultured with 100 ng/ml of HEL antigen overnight,
and cells were examined the next day by three-color
flow cytometry for surface expression of the activation
markers CD86, HEL, and B220. As expected, very few
anergic Cr21 Ig transgenic B cells responded to HEL
(Figures 3A, 3C, and 3I). This lack of response to HEL
is not explained by the reduced number of HEL-binding
B cells, as their frequency is similar in the Cr21 single-
and double-transgenic mice (Table 1). By contrast, the
frequency of CD861 Cr2null B2201 cells isolated from
single and double transgenic mice was similar (Figures
3B, 3D, and 3I). The response to HEL is specific in this
assay, as very few B2201 cells harvested from spleens
of either group of double-transgenic mice expressed
CD86 before culture (Figures 3E and 3F), and wild-type
(nontransgenic) B2201 splenic B cells do not show a
change in CD86 expression after overnight culture either
without or with HEL stimulation (Figures 3G and 3H). To
examine signal transduction, splenocytes isolated from
single- and double-transgenic mice were loaded with a
calcium-sensitive dye (fluo-3), exposed to lysozyme (100
ng/ml), and B2201 cells were analyzed by two-color flow
cytometry for release of Ca21i. As reported by Cooke et
al. (1994), cross-linking of mIgM with antigen failed to
induce significant Ca21i release in anergic Cr21 HEL-
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binding cells (Figures 3J, 3L, and 3N). By contrast, only
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Figure 2. Life Span of Cr2null HEL-Binding B
Cells Is Not Reduced by Presence of HEL
Self-Antigen
(A±D) Representative histograms of relative
BrdU fluorescence of HEL-binding B cells of
single- and double-transgenic Cr21 and
Cr2null mice.
(E) Scatter plot represents total numbers of
BrdU-negative HEL-binding B cells from five
lymph nodes per mouse. Horizontal bar for
each group of mice represents the mean
number of total cells. Results are from at least
three separate experiments. The asterisk in-
dicates statistical significance (p , 0.00008)
comparing number of BrdU-negative HEL-
binding B cells harvested from LNs of Cr21
and Cr2null double-transgenic mice.
a relatively modest impairment in Ca21i mobilization was one-third, respectively (32 6 5.3 3 106 versus 10 6 2.8 3
106, respectively [n $ 9]; and 34 6 6.4 3 106 versus 18 6observed in the treated Cr2null Ig transgenic B cells har-
vested from double-transgenic mice (Figures 3K, 3M, 5.0 3 106, respectively [n $ 4]). While this reduction
is more pronounced than that observed in double-and 3N). The frequency of Cr2null versus Cr21 HEL-bind-
ing cells that mobilized Ca21i during the 60±120 s time transgenic mice produced by breeding (Table 1), it is
comparable to that reported by Fulcher and Basten,interval was significantly greater (12% 6 3.9% versus
6% 6 1.3%, p , 0.01) (Figures 3L±3N). Thus, sHEL self- who examined older chimeric animals (3±4 months) as
used in this study (Fulcher and Basten, 1994). By con-antigen fails to completely anergize Cr2null HEL-binding
B cells, as they mobilize Ca21i and express the activation trast, a similar number of HEL-binding B cells was found
in spleens of single- and double-transgenic C4null chime-marker CD86 in response to antigenic stimulation ex
vivo. However, serum anti-HEL levels were undetectable ras (26 6 5.2 3 106 versus 27 6 5.8 3 106, respectively
[n $ 9]). Thus, significantly fewer HEL-binding B cellsas found for the anergic Cr2null double trasngenic mice
(data not shown). were found in spleens of C1 and C3null than in C4null
double-transgenic chimeras (10 6 2.8 3 106 or 18 6
5.0 3 106 versus 27 6 5.8 3 106; p , 0.00001 and , 0.003,HEL-Binding B Lymphocytes Are Not Anergized
by sHEL Self-Antigen in Mice Deficient in C4 respectively [n $ 8]). Consistent with these findings,
histological analysis revealed a reduction in the fre-To examine the importance of the complement proteins
C4 and C3 in negative selection of HEL-binding B cells quency of HEL-binding B cells in the splenic follicules
of double-transgenic C1 or C3null chimeras but not inin the transgenic model, chimeric mice were constructed
by engrafting BM harvested from C1 HEL-specific Ig C4null chimeras (data not shown).
Analysis of mature CD231 HEL-binding B cells in thetransgenic mice into either C4null , C3null, or C1 non- or
sHEL-transgenic recipients. This approach provides an peripheral LNs revealed a striking reduction in the num-
ber of transgenic B cells in the C1 and C3null double-alternative to breeding of transgenic mice as HEL-bind-
ing transgenic B cells are similarly anergized by sHEL transgenic mice compared to C4null double-transgenic
chimeras. Approximately 11-fold fewer HEL-binding Bself-antigen in chimeric mice as described above (Good-
now et al., 1995). A potential limitation with the chimeras cells mature and reach the LNs in the C1 compared to
C4null double-transgenic animals (0.5 6 0.3 3 104 versusis that bone marrow±derived cells from the C1 donor
could be sources of C4 or C3 protein in lymphoid tissues. 5.7 6 1.8 3 104, p , 0.00003 [n $ 4]). Three-fold fewer
mature transgenic B cells were identified within periph-Extrahepatic synthesis of C4 or C3 (Fischer et al., 1998b)
is not constitutive and C4 or C3 protein was not detected eral LNs of C3null compared to C4null double-transgenic
mice (2.1 6 1.1 3 104 versus 5.7 6 1.8 3 104, p , 0.0003in the serum of the respective chimeras (data not shown).
Characterization of BM chimeras 4±6 weeks after [n $ 8]). Thus, as found in the spleen, the number of HEL-
binding B cells is intermediate in C3null double-transgenictransplant by three-color flow cytometry confirmed a
frequency of HEL-binding B cells in single-transgenic chimeras compared to C1 and C4null animals. The finding
that deficiency in C4 alters negative selection of imma-chimeras similar to that found in the germline mice de-
scribed above (Table 1), i.e., approximately 80%±85% ture self-reactive B cells is consistent with results de-
scribed above with the Cr2null double-transgenic mice.of B2201 cells (Table 2). Flow cytometry analyses of
immature HEL-binding B cells in the C4null and C1 sHEL/ Interestingly, deficiency in serum C3 has less of an
effect.HEL Ig transgenic chimeras indicated a relative increase
in the level of mIgM on the surface of B cells harvested
from the C4null mice consistent with that observed with C4null HEL-Binding B Lymphocytes Respond
to Antigen Ex VivoCr2null double-transgenic mice (data not shown). Inter-
estingly, in the presence of sHEL self-antigen, the num- As a further measure of anergy, splenocytes isolated
from C1, C4null, and C3null single- and double-transgenicber of HEL-binding B cells in spleens of C1 and C3null Ig
transgenic chimeras was reduced by two-thirds and chimeras were characterized in vitro by three-color flow
B Cell Negative Selection Involves Complement
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Figure 3. Cr2null HEL-Binding B Cells Harvested from Double-Transgenic Mice Are Not Anergic Based on Expression of Activation Marker
CD86 and Mobilization of Intracellular Ca21i in Response to Antigen Stimulation Ex Vivo
(A±D) Representative flow cytometry results of HEL-binding splenocytes following overnight culture with 100 ng/ml of HEL and staining with
MAb specific for B220 and CD86 (B7±2). HEL1, B2201 cells harvested from Cr21 double-transgenic mice have an impaired response to HEL
self-antigen as expected from previous studies (Cooke et al., 1994). By contrast, only a modest decrease in responsiveness to antigen
stimulation was observed in Cr2null cells isolated from double-transgenic mice. Number in upper right quadrant represents percent of total
lymphocytes gated that are double positive for CD86 and B220. (E and F) Response to culture with antigen was confirmed as specific, as
very few B2201 cells isolated from the two groups of double-transgenic mice expressed CD86 ex vivo prior to culture with HEL, and (G and
H) wild-type spleen cells express background levels of CD86 ex vivo irrespective of culture without or with HEL. (I) Scatter plot summarizing
results from three separate experiments demonstrating a significant difference (p , 0.004, indicated by asterisk) in the frequency of CD861B2201
cells following overnight culture with HEL isolated from Cr2null compared to Cr21 double-transgenic mice. Horizontal bars represent means
for each group of mice analyzed. Results represent the percent of total B2201 cells that were positive for CD86 based on gate settings shown
in (A±D). (J±M) Representative flow cytometry results of splenocytes showing mobilization of Ca21i following brief stimulation with 100 ng/ml
of HEL. Results demonstrate that splenocytes harvested from Cr2null double transgenic mice retain responsiveness ex vivo to HEL antigen,
while Cr21 self-reactive cells are anergic as expected. Gated cells represent Ca21i measured for a time period of 60±120 s. (N) Scatter plot
represents summary of results from two separate experiments for analysis of frequency of B2201 cells, which mobilize Ca21i over the time
period of 60±120 s. The bar represents the mean and the asterisk indicates statistical significance (p , 0.01; comparison of cells harvested
from Cr21 and Cr2null double-transgenic mice).
cytometry for expression of the activation marker CD86 1.1% or 1.3% 6 0.45% versus 8.5% 6 2.6%, respec-
tively; n $ 5; p , 0.0001 or 0.00007, respectively) whenas described above. Following overnight culture with
HEL antigen, a relatively low frequency of CD861B2201 incubated with HEL antigen. Although, the frequency of
HEL-binding cells is less in the spleens of C1 and C3nullB cells was observed in C1 and C3null double- compared
to single-transgenic chimeric mice (7% 6 4.3% and chimeras than C4null double-transgenic chimeras, this
difference would not explain the overall increase in fre-4% 6 3% versus 77% 6 11.3% and 78% 6 3.9%, p ,
0.00003, respectively) (Figures 4A±4F and 4J). By con- quency of CD861B2201 cells in the later group or the
increased Ca21i mobilization by the C4null chimeric mice.trast, a similar frequency of CD861B2201 responding
cells was observed on comparison of single- and dou- Thus, C4 is important in induction of anergy in the dou-
ble-transgenic HEL model, but serum C3 does not playble-transgenic C4null chimeras (Figures 4B, 4E, and 4J).
Thus, a significantly higher proportion of the HEL-bind- a role in B cell tolerance.
ing B cells isolated from C4null than C1 or C3null chimeric
mice expressed CD86 in response to HEL antigen ex Autoimmune Disease Is Increased in lpr/lpr
vivo, i.e., 49% 6 19% versus 7% 6 4.3% or 4% 6 Mice Totally Deficient in either C4
3% (p , 0.00002 or 0.00001, respectively) (Figure 4J). or CD21/CD35 but Not C3
Likewise, both C1 and C3null chimeric double-transgenic The results from the well-characterized, high-affinity im-
mice had significantly impaired Ca21i mobilization com- munoglobulin transgenic model provide strong evi-
dence for a role for complement in negative selectionpared to C4null chimeric double transgenics (2.4% 6
Immunity
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of HEL-binding B cells; however, they raise the question
of whether complement is also important for mainte-
nance of tolerance to natural self-antigens, as is com-
monly found in SLE (e.g., nuclear antigens). To address
this question, we examined a murine model of lupus in an
lpr/lpr strain of mice (Theofilopoulos and Dixon, 1985).
These lupus-prone mice have a natural deficiency in
CD95 (Fas) that leads to disease presumably due to the
failure to eliminate self-reactive T and B lymphocytes
from the periphery (Takahashi et al., 1994). Severity of
disease is strain dependent, and in the C57BL/6 back-
ground Fas deficiency results in a mild form of the dis-
ease in which the mice have a normal life span and do
not develop glomerulonephritis. To examine the role of
complement in the mouse SLE model, Cr2null, C4null, or
C3null mice were bred to C57BL/6.lpr/lpr mice and char-
acterized for severity of disease.
A common phenotype of Fas deficiency is splenomeg-
aly and lymphadenopathy presumably due to the expan-
sion of a novel population of CD4- and CD8-negative
but B2201CD31 T lymphocytes. Complement-sufficient
lpr/lpr mice (C1lpr/lpr) on the mixed 129 3 C57BL/6
background have slight splenomegaly and lymphade-
nopathy at 13 and 17 weeks of age consistent with their
mild disease (Figures 5A and 5B). By contrast, lpr/lpr
mice deficient in either CD21/CD35 or C4 but not C3
have significantly increased mass of their cervical lymph
nodes at both 13 and 17 weeks of age; Cr2null lpr/lpr
mice also have significant splenomegaly (Figures 5A and
5B). One explanation for the increased sizes in spleen
and lymph nodes is that the C4null or Cr2null lpr/lpr mice
develop a more vigorous expansion of the double-nega-
tive CD31 T cell population, possibly resulting from in-
creased expansion of self-reactive B cells. This explana-
tion would be consistent with the observation that
lymphoproliferation and disease is reduced in B cell±
deficient MRL-lpr/lpr mice (Chan and Shlomchik, 1998).
A hallmark of lupus is autoantibodies against nuclear
antigens such as ribonuclear proteins, histones, and
double-strand DNA (dsDNA) (Cotran et al., 1994). To
determine if deficiency in complement affects produc-
tion of anti-nuclear or -dsDNA antibodies, sera were
collected from the four groups of lpr/lpr mice at 10, 13,
and 17 weeks of age and assayed by immunofluores-
cence and ELISA, respectively. Analysis of anti-nuclear
antibody (ANA) titers for the three groups of mice re-
vealed a striking increase in total IgG antibodies in the
C4- and CD21/CD35-deficient mice, while only back-
ground levels of autoantibody were found for the C1
lpr/lpr and C3null lpr/lpr mice (Figure 5C). Consistent with
increased ANA, both C4null and Cr2null lpr/lpr mice ex-
pressed significantly higher levels of anti-dsDNA anti-
bodies (Figure 5D). The finding of high titers of anti-
nuclear and -dsDNA antibodies supports our hypothesis
that SLE-related self-reactive B cells are not eliminated
in the absence of C4 or CD21/CD35 and that in the
presence of T cell help and self-antigen they secrete
autoantibody. A major pathogenic consequence of cir-
culating autoantibodies in SLE is deposition of immune
complexes within the kidney leading to glomerulone-
phritis, which can be fatal (Cotran et al., 1994). Examina-
tion of cryosections of kidneys by immunofluorescence
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revealed increased deposition of IgG in the glomeruli of
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Figure 4. HEL-Binding B Cells Harvested from C4null but Not C3null Chimeric-Double Transgenic Mice Respond to Antigen Ex Vivo and Express
the Activation Marker CD86 (B7±2)
(A±F) Representative flow diagram indicating frequency of B2201 splenocytes harvested from C1, C4null, or C3null single- and double-transgenic
mice, which express CD86 in response to antigen stimulation in vitro. Results reveal that HEL-binding B cells harvested from C4null double-
transgenic mice are responsive to HEL in vitro and therefore do not appear to be anergic. By contrast, HEL-binding B cells harvested from
C1 or C3null chimeric double-transgenic mice are anergized. Numbers in upper right quadrants indicates mean percent of B220/CD86 double-
positive cells out of total lymphocytes gated.
(G±I) Representative flow diagrams of HEL-binding B cells harvested from the three groups of double-transgenic mice and analyzed directly
without prior stimulation. Results reveal that despite presence of sHEL antigen in vivo the B cells do not appear to be activated.
(J) Scatter plot summarizing results from three separate experiments comparing frequency of CD861 cells out of total B2201 splenocytes
gated. Horizontal bars indicate mean values. Asterisk indicates statistical significance (p , 0.002) comparing frequency of CD861 splenocytes
harvested from C1 or C3null with C4null double-transgenic mice.
Cr2null or C4null lpr/lpr compared to C1 lpr/lpr mice, i.e., found that induction of anergy in HEL-binding self-reac-
tive B cells required expression of complement recep-of 100 glomeruli counted, 92%, 58%, and 15% were
tors CD21/CD35. Receptor-deficient mice showed apositive, respectively; n $ 3 mice per group (Figures 5L,
dramatic reduction in tolerance as the HEL-binding B5J, and 5F). A modest increase in IgG deposits was also
cells matured and accumulated within the peripheralobserved in glomeruli of C3null lpr/lpr mice despite their
lymphoid compartment at similar frequencies to C1relatively low levels of anti-nuclear and -dsDNA antibody
single-transgenic mice (Figure 2; Table 1). Cr2null trans-(Figure 5H). C3 deposition was also identified in the
genic B cells were not anergized by the presence ofglomeruli of C4 and CD21/CD35-deficient but not com-
self-antigen when analyzed in vitro, based on both mobi-plement-sufficient or C3null lpr/lpr mice (data not shown).
lization of Ca21i and expression of CD86 (Figure 3). Defi-Consistent with deposition of IgG and C3, increased
ciency in complement C4 leads to a similar loss of toler-hypercellularity and glomerular enlargement was found
ance in the HEL model, and the results parallel thosein the glomeruli of Cr2null and C4null but not C1 lpr/lpr
observed with Cr2null double transgenics (Figure 4; Tablemice (mean scores of 2±3, 1±2, and 1 for Cr2null, C4null,
2). Despite the reduction in anergy, HEL-specific anti-and C1 lpr/lpr, respectively, were assigned based on
body was not detected in the serum of the Cr2null or C4nullcriteria in Experimental Procedures) (Figures 5K, 5I, and
double-transgenic mice (data not shown). Interestingly,5E). Thus, C4null or Cr2null lpr/lpr mice have increased SLE-
deficiency in serum C3 protein had less of an effectlike autoantibodies and deposits of immune complexes
on tolerance. For example, the reduction in number ofwithin the glomeruli that can lead to severe glomerulone-
peripheral transgenic B cells in C3null chimeric doublephritis (Figures 5E±5L). Similar to human lupus, C3null lpr/
transgenics was intermediate between C1 and C4null chi-lpr mice did not have elevated autoantibody levels, and
meric mice. However, HEL-binding B cells harvestedonly a modest increase in IgG deposits was observed
from the C3null double transgenics remained unrespon-in the kidneys.
sive to antigen stimulation in vitro. A potential limitation
with the transgenic model is that the HEL self-antigen
Discussion binds with an unusually high affinity. Therefore, to ex-
tend our findings in a more natural model, we crossed
Our findings describe a novel role for complement in the three C-deficient strains to a strain that develops a
maintenance of B cell tolerance to soluble self-antigens. mild lupus-like disease. In this model, Fas deficiency
would not be expected to alter the proposed role of C4Using the HEL-Ig/sHEL double-transgenic model, we
Immunity
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Figure 5. Deficiency in Complement CD21/CD35 or C4 Results in Increased Lymphadenopathy, which Correlates with Increased Anti-Nuclear
and dsDNA Antibodies, Leading to Immune Deposits and Glomerulonephritis in lpr/lpr Mice
(A and B) Results demonstrate significant increase in mass of cervical lymph nodes at 13 and 17 weeks in Cr2null and C4null compared to C3null
and C1 lpr/lpr mice; Cr2null lpr/lpr mice also had significant splenomegaly at 13 and 17 weeks relative to C1 lpr/lpr. Scatter blot indicates mass
of spleens and cervical lymph nodes for individual mice at 13 and 17 weeks of age. Bars represent mean mass. Results are based on at least
three experiments with female mice. Asterisk represents statistical significance p , 0.02.
(C) Sera from C1 lpr/lpr, C4null lpr/lpr, C3null lpr/lpr, and Cr2null lpr/lpr were harvested at indicated times, and IgG titers were determined by
indirect immunofluorescence. Results reveal significantly higher titers of anti-nuclear antibody in Cr2null lpr/lpr mice at all three time points.
C4null lpr/lpr mice, which were not tested at 10 weeks, had high titers similar to Cr2null lpr/lpr mice at 13 and 17 weeks. Significantly, C3null lpr/
lpr mice did not have autoantibody titers elevated over C1lpr/lpr controls.
(D) Sera harvested as described above in (A) were analyzed by ELISA for IgG2B binding to dsDNA. Results demonstrate that C4null and Cr2null
lpr/lpr mice have significantly higher anti-dsDNA titers than complement-sufficient controls or C3null lpr/lpr at 13 and 17 weeks of age. IgG2B
isotype represents the major class of IgG in the anti-dsDNA antibody among the three groups of mice (data not shown). Results are from at
least three experiments with female mice. Each open circle represents an individual mouse. Asterisk indicates significance p , 0.04.
(E±L) Histological analyses of kidneys harvested from 4 groups of lpr/lpr mice: C1, C3null, C4null, and Cr2null. (F, H, J, and L) Indirect immunofluores-
cent analyses of cryosections reveal increased frequency of IgG deposits in glomeruli of Cr2null (92% of glomeruli) (L) and C4null (56% of
glomeruli) (J) mice but only intermediate to background levels in C3null (36% of glomeruli) (H) or C1 (12% of glomeruli) lpr/lpr mice (F). (E, G,
I, and K) Histological analysis of PAS-stained sections of kidneys indicates development of glomerulonephritis as characterized by hypercellular-
ity and glomerular thickening. Cr2null lpr/lpr mice have more severe disease than C4null, C3null, and C1 lpr/lpr mice with mean scores of 2±3, 2,
1±2 and 1, respectively (n $ 4 mice per group; see Experimental Procedures for scoring criteria). Note hyaline deposition and near end-stage
sclerotic lesion in Cr2null glomerulus (K). Magnification, 4003.
or CD35 in induction of anergy, as Fas is thought to be Despite a role for complement in the humoral response
to T-dependent antigens, this critical role is overcomeimportant in elimination, not induction, of anergic cells
(Rathmell et al., 1995). Importantly, deficiency in either in the production of autoantibody in the C4null and Cr2null
Fas-deficient mice. The observation that C3 deficiencyCD21/CD35 or C4 resulted in increased lymphadenopathy,
anti-nuclear and-dsDNA autoantibodies that correlated had no obvious affect on autoantibody levels is similar
to that found in human lupus.with increased renal deposits of IgG, and glomerulone-
phritis. These findings demonstrate that complement The fate of immature self-reactive B lymphocytes
within the bone marrow and peripheral lymphoid com-C4 and its receptors CD21/CD35 are important in main-
tenance of B cell tolerance against natural self-antigens. partment is largely determined by the strength of signal
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et al., 1996) (mixed 129/C57BL/6 backgrounds). Mice expressingmediated by the B cell receptor (BCR) in response to
transgenes encoding IgM/IgD heavy and light chain, high-affinitycross-linking by antigen (Nemazee and Burki, 1989; Erik-
HEL-specific antibody (MD4) (Goodnow et al., 1995) (both on C57BL/son et al., 1991; Goodnow, 1996). For example, in dou-
6 background) were crossed with C1 or Cr2null mice. Double-
ble-transgenic models in which the self-antigen is ex- transgenic C1 or Cr2null sHEL/anti-HEL mice were obtained by breed-
pressed on the membrane, self-reactive B cells are ing the respective single transgenics. Offspring were genotyped by
clonaly deleted in the BM (Nemazee and Burki, 1989; PCR using JH-specific primers (IgHF2 and IgHR1) to detect HEL Ig
transgenics and HEL3F and HEL4R primers were used to detectGoodnow, 1996). Thus, the concentration and affinity of
sHEL transgenics. Germline transgenic mice used for experimentsantigen and regulation of BCR signaling by molecules
were 5±8 weeks old. C3null, C4null, and C1 control chimeric mice weresuch as CD19 (Inaoki et al., 1997), CD45 (Cyster et al.,
constructed as described (Fischer et al., 1996). Briefly, 1 3 107 bone1996), or protein tyrosine phosphatase 1C (SHP-1) (Cys-
marrow cells (harvested from C1 HEL-specific Ig transgenic mice)
ter and Goodnow, 1995) can dramatically affect negative were injected intravenously into C3null, C4null, or C1 mice, which had
selection of self-reactive B cells. It is not clear how been tested previously for sHEL expression (irradiated twice with
soluble self-antigens are made available in negative se- 450 rads each at 3 hr apart) 1 hr after second irradiation. Chimeras
were rested for approximately 30 days before use. Serum levels oflection within the primary and secondary lymphoid com-
sHEL and anti-HEL antibody were assayed by ELISA as describedpartments. An explanation for our findings is that com-
(Goodnow et al., 1989). Briefly, sHEL levels were determined byplement enhances localization of soluble self-antigens
adding dilutions of serum to 96-well plates coated with HEL-specificto the primary and secondary lymphoid compartments.
MAb HyHEL-5 (5 mg/ml), followed by treatment with a second HEL-
Coreceptor signaling via C3d-coated self-antigens bind- specific MAb HyHEL-9 conjugated with biotin. HEL binding was
ing to CD21/CD19/Tapa-1 on B cells is not likely to play detected by adding strepavidin-alkaline phosphatase and develop-
an important role based on our results with the C3null ment with a color reaction. Similarly, serum anti-HEL levels were
assayed in single- and double-transgenic mice by adding dilutionsmice. We propose that complement enhances B cell
of sera to 96-well plates coated with HEL antigen (50 mg/ml) followedtolerance against highly conserved soluble antigens
by a goat anti-mouse IgM antibody conjugated with alkaline-phos-such as DNA and nuclear proteins (Carroll, 1998b). Re-
phatase (Southern Biotechnologies, Birmingham, AL) and color de-cent studies by Rosen and colleagues reported that
velopment. C57BL/6 lpr/lpr mice were purchased from Jackson Lab-
dying cells release surface blebs that contain these oratories (Bar Harbor, ME) and were bred with our Cr2null, C3null, or
types of antigens (Casciola-Rosen et al., 1994). Mice C4null mice. Cr2, C3, or C4 typing was performed as described, and
deficient in C1q spontaneously develop anti-nuclear au- lpr/lpr homozygosity was confirmed with PCR as described (Erikson
et al., 1991). All mice were homozygous for lpr and either homozy-toantibodies and glomerulonephritis, which correlates
gous Cr2null, C3null, or C4null. C1 controls represent homozygous 1/1with an accumulation of apoptotic bodies in the kidneys
offspring from mating 1/2 mice. At age 10, 13, or 17 weeks, mice(Botto et al., 1998). Recognition of nuclear antigens by
were bled and sacrificed, and spleen, cervical lymph nodes, andnatural antibody (IgM) (Coutinho et al., 1995) or directly
kidneys were harvested and weighed.
by C1q (Korb and Ahearn, 1997) would activate the early
classical pathway (C1-C4) leading to covalent attach- Flow Cytometry Staining and Analysis
ment of C4b. Uptake of C4b-coated self-antigens by Bone marrow, splenic, or lymph node mononuclear cells were pre-
CD35-bearing cells within the BM and secondary pared on a buoyant density gradient before staining and three-color
analysis was conducted on a FACSCalibur as described (Fischer etlymphoid compartment would provide a mechanism for
al., 1998a). Antibodies used in this study included fluorescein iso-concentration of self-antigens and insure contact with
thiocyanate (FITC)- or phycoerythrin (PE)-conjugated rat anti-mouseimmature self-reactive B cells. An alternative hypothesis
isotype-control antibodies (R35±95, R35±38), anti-CD45R (B220),is that deficiency in C1-C4 results in accumulation of
anti-CD23 (B3B4), anti-CD86 (GL1), and anti-IgMa (DS-1) mono-
aggregates of self-antigen that activate C3 (by alterna- clonal antibodies (all antibodies are from PharMingen, San Diego,
tive pathway) and break B cell tolerance via coreceptor CA). HEL-transgenic B cells were detected by staining with HEL-
signaling. This hypothesis seems unlikely to explain the biotin followed by streptavidin Cy-Chrome (PharMingen). HEL-biotin
was prepared using biotinamidocaproate N-hydroxysuccinimideimpaired tolerance in the HEL model, since Cr2null HEL-
(Sigma, St. Louis, MO) and standard protocols.binding B cells in double-transgenic mice do not appear
activated in vivo, i.e., high frequency of BrdU-negative
Analysis of Intracellular Calcium Ion Ca21i Fluxesmature B cells and low frequency of expression of the
Analysis was performed as described (Greimers et al., 1996). Spleno-activation marker CD86 expressed by unstimulated
cytes (107 cells/ml) were loaded with fluo-3/AM (Molecular Probes,
transgenic B cells. However, it is possible that both Eugene, OR), stained with anti-B220 MAb, washed twice, and diluted
mechanisms are involved in a complex autoimmune dis- to 106 cells/ml with 10 mM 4-(2-hydroxyethyl)piperazin-1-ethanesul-
ease such as lupus. fonic acid (HEPES)-buffered salt containing 137 mM NaCl, 5 mM
KCl, 1 mM Na2HPO4, 5 mM glucose, 1 mM CaCl2, 0.5 mM MgCl2,In summary, examination of complement deficiency in
and 1 g/liter BSA (pH 7.4). Cell suspensions were incubated at 37.58Ctwo well-defined murine models of peripheral tolerance
for 15 min before flow cytometry. After baseline unstimulated mea-reveals that complement C4 protein and the receptors
surements, a stimulus was added to the sample on the flow cytom-CD21/CD35 are involved in negative selection of self-
eter. A23187 (Sigma, St. Louis, MO), an antibiotic calcium ion iono-reactive B lymphocytes. These results not only provide phore, was used at 10 mM, HEL (Sigma, St. Louis, MO) was used
insight into the targeting of self antigens for mainte- at 100 ng/ml, and goat anti-mouse IgM, F(ab9)2 fragment, (Jackson
nance of B cell tolerance; but provide an explanation for ImmunoResearch Laboratories Inc.,ME) was used at 10 mg/ml. Total
the long-standing paradox of how an immune deficiency time of acquisition per sample was 300 s.
predisposes to SLE.
BrdU Labeling and Analysis
Experimental mice were injected intraperitoneally with 0.6 mg ofExperimental Procedures
BrdU (Sigma) in 0.2 ml sterile, pyrogen-free Hank's balanced salt
solution at 12 hr intervals for 7 days. BrdU incorporation was deter-Mice
mined according to published procedure (Allman et al., 1992).Mice transgenic for soluble hen egg lysozyme (sHEL) (ML5) were
bred with C1, Cr2null, C3null, and C4null mice (Ahearn et al., 1996; Fischer Briefly, lymph node or splenic MNCs were purified as described
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above and then permeabilized by drop-wise addition of ice-cold thank Dr. E. Tsitsikov (Children's Hospital, Boston) for help with the
Ca21i mobilization assays and Dr. Henry Warren (Center for Animal95% ethanol, washed, and fixed in phosphate-buffered saline with
1% paraformaldehyde plus 100 U/ml DNAse to partially degrade Resources and Comparative Medicine, Harvard Medical School)
for examining the pathology of kidney sections. We also thank Dr.and denature their chromatin. Subsequently, treated cells were
stained with FITC-labeled antibody to BrdU (MAb B44; Becton Dick- Minghe Ma, Ms. Junrong Xia, and Ms. Xiaoning Zhou for help with
the mice. M. C. C. is supported by grants from the National Institutesinson) and counter-stained with HEL-biotin (as described above)
and B220 MAb; cells were analyzed by two-color flow cytometry. of Health and Cambridge Antibodies, Inc., Cambridge, United
Kingdom.
In Vitro Activation Assay
Splenic mononuclear cells were purified and cultured overnight with
Received August 8, 1998; revised Octobter 8, 1998.100 ng/ml of hen egg lysozyme as described (Fischer et al., 1998a).
To detect activated HEL-binding transgenic B cells, splenic MNCs
were stained with HEL-biotin and B220-FITC followed by streptavi-
Referencesdin-Cy-Chrome and counterstained with PE-labeled anti-CD86
(B7±2) MAbs (all obtained from PharMingen).
Allman, D.M., Ferguson, S.E., and Cancro, M.P. (1992). Peripheral
B cell maturation II: heat-stable antigen high splenic B cells are anAnti-Nuclear Antibodies
immature developmental intermediate in the production of long-Anti-nuclear antibodies (ANA) were determined using Hep2-coated
lived marrow-derived B cells. J. Immunol. 151, 431±444.slides (Binding Site Ltd, Birmingham, England) incubated with serial
Agnello, V. (1978). Association of systemic lupus erythematosusdilutions of mouse sera in PBS. After washing, goat anti-mouse IgG
and SLE-like syndromes with hereditary and acquired complementlabeled with FITC was used as secondary antibody (Sigma). After
deficiency states. Arthritis Rheum. 21, 146±152.mounting with 10% glycerol in PBS, slides were viewed by fluores-
cent microscopy and the last positive dilution determined by com- Ahearn, J.M., Fischer, M.B., Croix, D., Goerg, S., Ma, M., Xia, J.,
parison with wild-type mouse control serum at 1:50 dilution and Zhou, X., Howard, R.G., Rothstein, T.L., and Carroll, M.C. (1996).
mean of titers were calculated for each group. Disruption of the Cr2 locus results in a reduction in B-1a cells and
in an impaired B cell response to T-dependent antigen. Immunity
Detection of Anti-dsDNA Autoantibodies 4, 251±262.
Anti-dsDNA-ELISA was performed as described (Emlen et al., 1990). Botto, M., Dell'Agnola, C., Bygrave, A.E., Thompson, E.M., Cook,
Briefly, avidin (Sigma; affinity purified from egg white) was diluted H.T., Petry, F., Loos, M., Pandolfi, P.P., and Walport, M.J. (1998).
in ELISA coating buffer (0.05 M carbonate [pH 9.6]) to 10 mg/ml and Homozygous C1q deficiency causes glomerulonephritis associated
incubated overnight at 48C in 96-well microtiter plate. Wells were with multiple apoptotic bodies. Nat. Genet. 19, 56±59.
washed three times with PBS 1 0.02% Tween (PBST) between each
Carroll, M.C. (1998a). The role of complement and complement re-
step. Next, plates were incubated 1 hr at room temperature (or
ceptors in induction and regulation of immunity. Annu. Rev. Immu-
overnight at 48C) with photobiotinylated DNA (1 mg/ml) (prepared
nol. 16, 545±568.
according to manufacturer's protocol; Sigma) diluted in PBS and
Carroll, M.C. (1998b). The lupus paradox. Nat. Genet. 19, 3±4.then blocked with 1% BSA/PBS for 1 hr at 378C. Serum samples
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